Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ARNDTS D")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

DRUG EFFECTS ON MYOCARDIAL 45CA UPTAKE IN CONSCIOUS RATS. = EFFETS DE DIVERS MEDICAMENTS SUR LA CAPTATION DE 45CA PAR LE MYOCARDE DU RAT EVEILLEARNDTS D.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 8; PP. 1279-1284; ABS. ALLEM.; BIBL. 27 REF.Article

DEVELOPMENT AND QUALITY CONTROL OF A HIGHLY SENSITIVE RADIOIMMUNOASSAY FOR ALINIDINEARNDTS D; STAHLE H.1981; J. PHARMACOL. METHODS; ISSN 0160-5402; USA; DA. 1981; VOL. 6; NO 2; PP. 109-120; BIBL. 10 REF.Article

NEW ASPECTS IN THE METABOLISM OF ALINIDINE IN MANARNDTS D; FORSTER HJ.1981; EUR. J. DRUG METAB. PHARMACOKINET.; ISSN 0378-7966; CHE; DA. 1981; VOL. 6; NO 4; PP. 313-315; BIBL. 7 REF.Article

MASS SPECTRAL ANALYSIS OF GLUCURONIDES FROM SYMPATHOMIMETIC HYDROXYPHENYLALKYLAMINOETHENOLS.POOK KH; ROMINGER KL; ARNDTS D et al.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 10; PP. 1513-1518; BIBL. 11 REF.Article

ALINIDINE PHARMACOKINETICS FOLLOWING ACUTE AND CHRONIC DOSINGHARRON DWG; ARNDTS D; SHANKS RG et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 13; NO 6; PP. 821-827; BIBL. 9 REF.Article

DEVELOPMENT OF A RIA FOR CLONIDINE AND ITS COMPARISON WITH THE REFERENCE METHODSARNDTS D; STAEHLE H; FOERSTER HJ et al.1981; J. PHARMACOL. METHODS; ISSN 0160-5402; USA; DA. 1981; VOL. 6; NO 4; PP. 295-307; BIBL. 12 REF.Article

PHARMACOKINETICS AND METABOLISM OF 14C-LABELLED ALINIDINE IN MAN AND DOGSARNDTS D; LEB G; FOERSTER HJ et al.1981; EUR. J. DRUG METAB. PHARMACOKINET.; ISSN 0378-7966; CHE; DA. 1981; VOL. 6; NO 3; PP. 225-236; BIBL. 14 REF.Article

EXPERIMENTAL INVESTIGATION OF POSSIBLE CARDIOTOXIC EFFECTS ON THE OFFSPRINGS OF RATS TREATED WITH HIGH DOSES OF FENOTEROL.NOTMAN J; ROMINGER KL; NIGGESCHULZE A et al.1977; J. PERINAT. MED.; GERM.; DA. 1977; VOL. 5; NO 5; PP. 206-213; ABS. ALLEM. FR.; BIBL. 10 REF.Article

NEW ASPECTS OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CLONIDINE IN MANARNDTS D; DOEVENDANS J; KIRSTEN R et al.1983; EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0031-6970; DEU; DA. 1983; VOL. 24; NO 1; PP. 21-30; BIBL. 26 REF.Article

PHARMAKOKINETIKEN VON CLONIDIN UND CHLORTHALIDON NACH SUBAKUTER GABE EINES FIXEN KOMBINATIONSPRAEPARATES IN VERGLEICH ZU CLONIDIN ALS MONORETARDPRAEPARAT = PHARMACOCINETIQUE DE LA CLONIDINE ET DU CHLORTHALIDON APRES L'ADMINISTRATION SUBAIGUE D'UNE PREPARATION ASSOCIEE FIXEE PAR COMPARAISON A LA CLONIDINE SOUS FORME DE PRODUIT RETARD UNIQUEARNDTS D; DOEVENDANS J; ARENDT G et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 11; PP. 1954-1957; ABS. ENG; BIBL. 8 REF.Article

Ω-Conotoxin GVIA potently inhibits the currents mediated by P2X receptors in rat DRG neuronsLALO, U. V; PANKRATOV, Yu V; ARNDTS, D et al.Brain research bulletin. 2001, Vol 54, Num 5, pp 507-512, issn 0361-9230Article

An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidineHARRON, D. W. G; ARNDTS, D; FINCH, M et al.British journal of clinical pharmacology. 1983, Vol 16, Num 4, pp 451-455, issn 0306-5251Article

  • Page / 1